Kasr Alainy medical school
Cairo, 12111, Egypt
NCT Number: NCT06946121
Procedure:
The procedure was done in the lithotomy position during the postmenstrual period.
We used a 30° angle 2.9 mm rigid hysteroscopy with 3.8 mm diagnostic sheath [TEKNO®, LIGHT XA 180, Germany].
Vaginoscopic approach was used for insertion of the hysteroscopy in all cases (no use of speculum or tenaculum).
The hysteroscopy was gently introduced into the uterine cavity after visualization of the cervix and identification of the external os.
We used saline as the distension medium and the maximum pressure was set at 70 to 80 mm Hg by an automated hysteroscopic pump system (Hysteromat II, Karl Storz), which automatically measured intrauterine fluid pressure. In lidocaine group: we added 5 ml of lidocaine 2% to 500 ml of saline solution that was used as a distention medium.
The uterine cavity and tubal ostia were systematically visualized. All procedures were done by an operator using the same equipment.
Looking for future studies?
Notify Me18 year–60 year
Female
Interventional
Not applicable
Cairo, 12111, Egypt
A written consent was taken from eligible women on admission after explaining the aim of the research, procedure, expected value, outcome, and possible adverse effects, with full details provided to them. They were informed that their participation in this study is voluntary and they may refuse to participate or withdraw from the study at any time.
After fulfilling inclusion and exclusion criteria, patients were equally randomized by simple randomization with a 1:1 allocation ratio into two groups using computer-generated random numbers. The envelopes were kept in the office hysteroscopy room in a closed box. Each of the envelopes was taken out of the box sequentially according to the order of women attendance.
Procedure:
The procedure was done in the lithotomy position during the postmenstrual period.
We used a 30° angle 2.9 mm rigid hysteroscopy with 3.8 mm diagnostic sheath [TEKNO®, LIGHT XA 180, Germany].
Vaginoscopic approach was used for insertion of the hysteroscopy in all cases (no use of speculum or tenaculum).
The hysteroscopy was gently introduced into the uterine cavity after visualization of the cervix and identification of the external os.
We used saline as the distension medium and the maximum pressure was set at 70 to 80 mm Hg by an automated hysteroscopic pump system (Hysteromat II, Karl Storz), which automatically measured intrauterine fluid pressure. In lidocaine group: we added 5 ml of lidocaine 2% to 500 ml of saline solution that was used as a distention medium.
The uterine cavity and tubal ostia were systematically visualized. All procedures were done by an operator using the same equipment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Age ≥ 18 years old.
Indications of diagnostic office hysteroscopy as:
Suspicion of the intracavitary lesion. Abnormal uterine bleeding. Abnormal endometrial thickening. Postmenopausal bleeding. Mullerian congenital anomaly. Removal of foreign bodies. Undergoing the procedure to assess the endocervical canal, uterine cavity, and tubal ostia for infertility.
Exclusion criteria
Unable to exclude pregnancy Acute pelvic infection Active genital herpes Profuse bleeding at the time of the procedure. Any usage of analgesic agent on the day of the procedure. Failure of entry of the cervical canal requiring cervical dilatation. Any additional procedure during the procedure: polypectomy, biopsy and adhesiolysis.
Patient refusal to participate in the study.
50 women undergoing diagnostic outpatient office hysteroscopy proceeded by infusions of intrauterine lidocaine 2% and normal saline at room temperature.
50 women undergoing diagnostic outpatient office hysteroscopy using warmed normal saline distention medium.
Time frame: at time of hysteroscopy and 15 minutes after it
using visual analogue scale
Cairo University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07713134
Analgeisa, Hysteroscopy
Tangshan, Hebei, China
View Trial DetailsNCT07641595
Cervical Preparation, Evening Primorose Oil
Sohag, Egypt
View Trial DetailsNCT06767644
Hysteroscopy
Cairo, Egypt
View Trial DetailsNCT07358624
Behavior, Health Behavior
Bab Saadoun, Tunisia
View Trial Details